NCT07121842View on ClinicalTrials.gov

Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

July 31, 2027

Conditions
Glioblastoma
Interventions
DIAGNOSTIC_TEST

Extended MRI

The MRI protocol for every clinical follow-up MRI scan is extended with 15 minutes to add the APTw-CEST scan.

Trial Locations (4)

Unknown

NOT_YET_RECRUITING

Amsterdam UMC, Amsterdam

RECRUITING

Leiden UMC, Leiden

RECRUITING

Erasmus MC, Rotterdam

RECRUITING

UMC Utrecht, Utrecht

Sponsors
All Listed Sponsors
collaborator

UMC Utrecht

OTHER

collaborator

LeidenUMC

UNKNOWN

collaborator

Amsterdam UMC, location VUmc

OTHER

lead

Erasmus Medical Center

OTHER

NCT07121842 - Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI | Biotech Hunter | Biotech Hunter